Literature DB >> 29130147

Callous-Unemotional Traits Modulate Brain Drug Craving Response in High-Risk Young Offenders.

Gina M Vincent1,2, Lora M Cope3, Jean King4, Prashanth Nyalakanti5, Kent A Kiehl6,7.   

Abstract

Adults with psychopathy have a high propensity for substance abuse, generally starting from a young age. This investigation tested hypotheses about differences in the neural responses associated with drug craving among high-risk young offenders with histories of abuse of stimulants and other drugs as a function of psychopathic traits. Fifty-four male adolescents (44 with a history of stimulant abuse and 10 controls) incarcerated at a maximum-security facility (M age = 17.08 years) completed a drug-cue exposure task while brain hemodynamic activity was monitored using functional magnetic resonance imaging (fMRI) with a mobile MRI scanner stationed at the facility. Psychopathic traits were assessed using the Hare Psychopathy Checklist: Youth Version (PCL:YV). In the stimulant abuser group, drug cues elicited activity in classic reward circuitry. Consistent with studies of adult psychopathic traits and substance abuse, there was a negative association between PCL-YV scores and hemodynamic response related to drug craving in the amygdala and ACC in youth with a history of stimulant abuse. However, there were considerably more negative associations between the PCL:YV and hemodynamic response among youth than adults and this was primarily due to callous-unemotional traits rather than interpersonal or behavioral traits. The implications for how personality traits modulate motivations for drug-seeking behavior among adolescent offenders are discussed.

Entities:  

Keywords:  Brain imaging; Craving, cocaine; Delinquency; Drug abuse; Psychopathic traits

Mesh:

Year:  2018        PMID: 29130147      PMCID: PMC5949254          DOI: 10.1007/s10802-017-0364-8

Source DB:  PubMed          Journal:  J Abnorm Child Psychol        ISSN: 0091-0627


  58 in total

1.  Error processing and the rostral anterior cingulate: an event-related fMRI study.

Authors:  K A Kiehl; P F Liddle; J B Hopfinger
Journal:  Psychophysiology       Date:  2000-03       Impact factor: 4.016

2.  Behavioral disinhibition and the development of substance-use disorders: findings from the Minnesota Twin Family Study.

Authors:  W G Iacono; S R Carlson; J Taylor; I J Elkins; M McGue
Journal:  Dev Psychopathol       Date:  1999

3.  Limbic activation to cigarette smoking cues independent of nicotine withdrawal: a perfusion fMRI study.

Authors:  Teresa R Franklin; Ze Wang; Jiongjiong Wang; Nathan Sciortino; Derek Harper; Yin Li; Ron Ehrman; Kyle Kampman; Charles P O'Brien; John A Detre; Anna Rose Childress
Journal:  Neuropsychopharmacology       Date:  2007-03-21       Impact factor: 7.853

4.  Altered resting-state functional connectivity in cortical networks in psychopathy.

Authors:  Carissa L Philippi; Maia S Pujara; Julian C Motzkin; Joseph Newman; Kent A Kiehl; Michael Koenigs
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

Review 5.  Classical conditioning in drug-dependent humans.

Authors:  C P O'Brien; A R Childress; A T McLellan; R Ehrman
Journal:  Ann N Y Acad Sci       Date:  1992-06-28       Impact factor: 5.691

6.  Associations between behavioral disinhibition and cocaine use history in individuals with cocaine dependence.

Authors:  James J Prisciandaro; Jeffrey E Korte; Aimee L McRae-Clark; Kathleen T Brady
Journal:  Addict Behav       Date:  2012-06-02       Impact factor: 3.913

Review 7.  Psychopathic traits from an RDoC perspective.

Authors:  R J R Blair
Journal:  Curr Opin Neurobiol       Date:  2014-10-27       Impact factor: 6.627

8.  Reward-related reversal learning after surgical excisions in orbito-frontal or dorsolateral prefrontal cortex in humans.

Authors:  J Hornak; J O'Doherty; J Bramham; E T Rolls; R G Morris; P R Bullock; C E Polkey
Journal:  J Cogn Neurosci       Date:  2004-04       Impact factor: 3.225

Review 9.  Neurocircuitry of addiction.

Authors:  George F Koob; Nora D Volkow
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

10.  THE CRIMINAL PSYCHOPATH: HISTORY, NEUROSCIENCE, TREATMENT, AND ECONOMICS.

Authors:  Kent A Kiehl; Morris B Hoffman
Journal:  Jurimetrics       Date:  2011
View more
  7 in total

Review 1.  Psychopathy.

Authors:  Stephane A De Brito; Adelle E Forth; Arielle R Baskin-Sommers; Inti A Brazil; Eva R Kimonis; Dustin Pardini; Paul J Frick; Robert James R Blair; Essi Viding
Journal:  Nat Rev Dis Primers       Date:  2021-07-08       Impact factor: 52.329

Review 2.  Recent neuro-imaging findings with respect to conduct disorder, callous-unemotional traits and psychopathy.

Authors:  Robert James R Blair; Ru Zhang
Journal:  Curr Opin Psychiatry       Date:  2020-01       Impact factor: 4.787

3.  Neuroimaging Metrics of Drug and Food Processing in Cocaine-Dependence, as a Function of Psychopathic Traits and Substance Use Severity.

Authors:  William J Denomme; Isabelle Simard; Matthew S Shane
Journal:  Front Hum Neurosci       Date:  2018-09-04       Impact factor: 3.169

Review 4.  Addiction and the Dark Triad of Personality.

Authors:  Emanuel Jauk; Raoul Dieterich
Journal:  Front Psychiatry       Date:  2019-09-17       Impact factor: 4.157

Review 5.  Dysfunctional neurocognition in individuals with clinically significant psychopathic traits
.

Authors:  Robert James R Blair
Journal:  Dialogues Clin Neurosci       Date:  2019-09       Impact factor: 5.986

6.  Psychosocial Factors Predict the Level of Substance Craving of People with Drug Addiction: A Machine Learning Approach.

Authors:  Hua Gong; Chuyin Xie; Chengfu Yu; Nan Sun; Hong Lu; Ying Xie
Journal:  Int J Environ Res Public Health       Date:  2021-11-19       Impact factor: 3.390

7.  Adolescent Psychopathic Traits Negatively Relate to Hemodynamic Activity within the Basal Ganglia during Error-Related Processing.

Authors:  J Michael Maurer; Vaughn R Steele; Gina M Vincent; Vikram Rao; Vince D Calhoun; Kent A Kiehl
Journal:  J Abnorm Child Psychol       Date:  2019-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.